Work

A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *

Year: 1996

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: European Journal of Cancer

DOI: 10.1016/0959-8049(95)00014-3

Authors: W. Jonat, A. Howell, C. Blomqvist, W. Eiermann, G. Winblad, C. Tyrrell, L. Mauriac, H. Roche, S. Lundgren, R. Hellmund, M. Azab

Institutions: University Medical Center Hamburg-Eppendorf, The Christie Hospital, Helsinki University Hospital, München Klinik, Plymouth Hospital, Institut Bergonié, Institut Claudius Regaud, AstraZeneca (United Kingdom)

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2096840197

FWCI: 8.992

Cites: 39

Cited by: 255

Related to: 10